Tag: GSK
GSK sales of RSV vaccine surpass US$1.5B on back ...
Posted by Editor | Feb 6, 2024 | LATEST NEWS, Medical Devices & Innovations, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
GSK completes US$1.4 B acquisition of Aiolos Bio
by Editor | Feb 19, 2024 | LATEST NEWS, WORLD NEWS | 0
USA – In a significant expansion of GSK’s respiratory biologics portfolio, the company has successfully concluded the acquisition of Aiolos Bio for a deal potentially reaching US$1.4 billion.
Read MoreUAE, GSK join forces to advance personalized healthcare
by Editor | Feb 9, 2024 | AFRICAN & MIDDLE EAST NEWS, Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing | 0
UAE—The Department of Health – Abu Dhabi (DoH) has signed a Memorandum of Understanding...
Read MoreGSK sales of RSV vaccine surpass US$1.5B on back of strong demand in US
by Editor | Feb 6, 2024 | LATEST NEWS, Medical Devices & Innovations, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UK – GlaxoSmithKline (GSK) sold over US$1.5 billion worth of its recently launched...
Read MoreGSK’s Nucala secures NMPA approval for severe asthma treatment
by Editor | Jan 18, 2024 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
CHINA – China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab)...
Read MoreGSK’s Jemperli secures European approval for advanced endometrial cancer treatment
by Editor | Dec 11, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM — GlaxoSmithKline (GSK) has achieved a significant milestone as the European...
Read MoreGSK expands portfolio with acquisition of Hepatitis B Candidate and continues to thrive with Arexvy RSV vaccine
by Editor | Nov 7, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM —GSK has acquired the rights to Arrowhead Pharmaceutical’s hepatitis B...
Read MoreGSK’s Arexvy RSV vaccine surges in the market, outpacing rival Pfizer
by Editor | Nov 2, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM — GlaxoSmithKline (GSK) has unveiled impressive sales figures for its new Arexvy...
Read MoreGSK enters US$20 million deal with 23andMe to harness DNA data for drug discovery
by Editor | Oct 31, 2023 | LATEST NEWS, Science, Technology & Research, WORLD NEWS | 0
UNITED KINGDOM — 23andMe, a leading US-based genetic-testing company, and GSK have renewed their...
Read MoreViiV Healthcare and Shutterstock Studios join forces to challenge outdated HIV perceptions
by Editor | Sep 22, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — In a world often clouded by misconceptions and stereotypes, ViiV Healthcare has taken a...
Read MoreGSK’s Ojjaara wins FDA approval for myelofibrosis patients battling anaemia
by Editor | Sep 18, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM — GSK’s myelofibrosis therapy, Ojjaara, also known as momelotinib, has...
Read MoreGSK & other corporate leaders urge EU to slash greenhouse gas emissions by 90% by 2040
by Editor | Sep 8, 2023 | LATEST NEWS, WORLD NEWS | 0
UNITED KINGDOM — British pharma giant GSK, alongside other corporate leaders, Coca-Cola, Unilever,...
Read MoreGlaxoSmithKline (GSK) Nigeria to cease operations amidst challenges and market shifts
by Editor | Sep 8, 2023 | AFRICAN & MIDDLE EAST NEWS, LATEST NEWS, Pharmaceuticals & Manufacturing | 0
NIGERIA — GlaxoSmithKline (GSK) Nigeria has announced its decision to withdraw from the Nigerian...
Read More